![Suresh de Silva](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Suresh de Silva
Directeur Technique/Scientifique/R&D chez
SHATTUCK LABS, INC.
Profil
Suresh de Silva is currently Investments Manager at UB Finance Plc and Chief Scientific Officer at Shattuck Labs, Inc. Formerly, Dr. de Silva was Executive Director-Research & Development at Scorpius Holdings, Inc. from 2017 to 2018.
Education includes graduate and doctorate degrees from Rochester Christian University and an undergraduate degree from the University of Colombo.
Postes actifs de Suresh de Silva
| Sociétés | Poste | Début |
|---|---|---|
| SHATTUCK LABS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2023 |
| UB FINANCE PLC | Corporate Officer/Principal | - |
Anciens postes connus de Suresh de Silva
| Sociétés | Poste | Fin |
|---|---|---|
| SCORPIUS HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | 01/12/2018 |
Formation de Suresh de Silva
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
59
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Rochester Christian University
 Rochester Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scorpius Holdings, Inc.
 Scorpius Holdings, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of therapies | Health Technology |
University of Colombo
 University of Colombo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UB Finance Co. Ltd.
 UB Finance Co. Ltd. Finance/Rental/LeasingFinance Provides asset backed lending and mortgage loan services | Finance |
Shattuck Labs, Inc.
 Shattuck Labs, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for inflammatory and immune-mediated diseases | Health Technology |
